Background and Purpose-Improvement of efficiency of gene transfer to e
ndothelium could be useful for several applications. We tested the hyp
othesis that cationic nonviral molecules augment adenovirus-mediated g
ene transfer to blood vessels, perhaps by alteration of the surface ch
arge of adenovirus and facilitation of binding to endothelium. Methods
-Carotid arteries from rabbits were incubated in vitro for 0.5 to 2 ho
urs with an adenoviral vector alone or noncovalent complexes of adenov
irus with poly-L-lysine (a cationic polymer) or lipofectin (a cationic
lipid). Binding of adenovirus to the vessels was evaluated immediatel
y after incubation with virus, and assay of transgene (beta-galactosid
ase) activity and histochemistry were performed 24 hours after gene tr
ansfer. To determine whether cationic molecules can be used to augment
alteration of vascular function by adenovirus-mediated gene transfer,
we also examined effects on gene transfer of endothelial nitric oxide
synthase, Results-Assay of beta-galactosidase activity indicated that
both cationic molecules increased transgene expression in vessels by
approximate to 5- to 6-fold. In contrast, when endothelium was removed
from the vessels after gene transfer, poly-L-lysine and lipofectin di
d not significantly increase transgene activity. Histochemistry for be
ta-galactosidase also suggested that the adenovirus-cationic molecule
complexes augmented transgene expression mainly in the endothelium. In
addition, we found that complexing adenovirus with cationic molecules
increased binding of adenovirus to the vessels, After gene transfer w
ith recombinant adenovirus containing endothelial nitric oxide synthas
e, calcium ionophore (A23187) produced greater relaxation of vessels t
reated with adenovirus complexed with poly-L-lysine or lipofectin than
those treated with adenovirus alone, Conclusions-Cationic molecules i
mprove the efficiency of adenovirus-mediated gene transfer to blood ve
ssels.